from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0240/vapC24

LFCtreatmentdescriptionclass of inhibitor

-0.267

Amikacinug/mL Amikacintranslation

0.294

Cap5-10ug/mL Capreomycintranslation

0.240

Rox10-50 ug/mL Roxithromycintranslation

0.733

SM2-5 ug/mL Streptomycintranslation

0.270

Tet5-10 ug/mL Tetracyclinetranslation

-0.262

Rif0.2-5ug/mL Rifampicintranscription

-0.890

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.690

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.025

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.435

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.619

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.209

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.270

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.462

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.641

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.144

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.832

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.235

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.012

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.298

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.725

KCN5-20 ug/mL Potassium cyaniderespiration

0.230

NaN30.2-2 mM Sodium aziderespiration

-0.158

Nigericin50 uM Nigericinrespiration

0.210

TRC10-150 ug/mL Triclosanrespiration

-1.548

TRZ10-25 ug/mL Thioridazinerespiration

3.224

Valinomycin0.5-10 uM Valinomycinrespiration

0.145

ZnSO42 mM ZnSO4respiration

1.275

menadione6-10 ug/mL Menadionerespiration

-0.490

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.139

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.567

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.319

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.012

NRP_1Non-replicating persistence stage 1dosRassociated

-0.375

Amp0.2mg/mL AmpicillincellWall

-0.405

Cephalexin20-100 ug/mL CephalexincellWall

-0.333

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.263

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.214

EMB10-20 ug/mL EthambutolcellWall

-0.457

Eta12-40 ug/mL EthionamidecellWall

-0.140

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.250

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.836

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.673

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.333

BZA0.12 mg/mL BenzamidearomaticAmides

0.322

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.300

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.945

H2O24 mM hydrogen peroxideDNAdamaging

-0.643

Levo10 ug/mL LevofloxacinDNAdamaging

-0.104

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.756

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.360

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.106

UVUV-irradiationDNAdamaging

1.076

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.599

Antimycin12.5-50 ug/mL Antimycin A?

-0.653

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.441

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.558

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.769

PA8240.2-2 ug/mL PA-824?

0.168

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.035

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.476

Verapamil50 uM Verapamil?

-0.105

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.318

methoxatin10-20 ug/mL Methoxatin?